Data from Oncomine (https://www.oncomine.org/) demonstrated that BAX was expressed at low levels, while BCL2 was expressed at high levels in breast cancer tumors compared to normal tissues (Figures 7C, S3). This evidence concerns the gene BAX and breast cancer.